Treatment of Franklin's Disease in Israel

Each patient receives a thoroughly developed therapy plan. It takes into account all aspects of the disease, including genetic and molecular characteristics. The Ichilov clinic implements the latest developments in medicine, including the newest types of immunotherapy, monoclonal antibodies, and personalized chemotherapy protocols.

The institution is equipped with advanced medical technologies, allowing for accurate diagnosis and effective treatment. Treatment is carried out by a multidisciplinary team, including hematologists, oncologists, and specialists from other fields. The medical center conducts clinical trials of the latest drugs and therapeutic methods and has extensive experience in successful bone marrow and stem cell transplants.

About the Disease

Franklin's syndrome is the most common type of heavy chain immunoglobulin disease. The pathology belongs to the group of "paraproteinemic hematoblastoses" (paraproteinemic leukemias) in the category of diseases associated with chronic lymphocytic leukemias. The peculiarity of the disease is related to problems in the production of immunoglobulins, leading to the appearance of fragments of heavy chain immunoglobulins - atypical proteins (paraproteins) in the blood and urine.

The heavy chain disease was first diagnosed in 1963 by Dr. E. S. Franklin. A year later, four cases of the pathology were simultaneously identified, observed by E. F. Osserman and K. Takatsuki, and the term "heavy chain disease" was introduced into medical terminology. The most common form is IgA heavy chain disease. In addition, subtypes of IgG and IgM heavy chain diseases are distinguished.

Franklin's disease is a plasma cell disorder with the secretion of heavy chain fragments, where there is not post-synthetic but abnormal cellular synthesis. Modern medicine cannot explain the reasons for the breakdown of structural genes, resulting in a failure in the coding of the constant variable region of immunoglobulins.

The symptoms of α-HCD can be extensive and diverse. Clinical signs are mostly similar to the symptoms of lymphoma and lymphoproliferative diseases. As a result, anemia, weight loss, general weakness, and malaise develop. The disease may also manifest as hypoproteinemia.

Treatment Methods for the Disease

Due to the rarity and insufficient study of Franklin's disease, not every medical center is capable of providing competent and effective treatment. The Ichilov clinic employs specialists with practical experience in treating this rare pathology. The complex of therapeutic measures varies depending on the specific case. The classical treatment scheme includes corticosteroids, cytotoxic drugs, and broad-spectrum antibiotics. A well-selected program ensures improvement in condition and long-term remission.

Chemotherapy

Chemotherapy for the treatment of heavy alpha chain disease is based on a systemic approach using chemotherapeutic drugs. The goal of therapy is to destroy atypical cells or block their proliferation. The oncologist selects the chemotherapy protocol based on the stage of the disease, the overall condition of the patient, and their response to previous treatments. Each protocol is adapted to the specific conditions of the patient.

To maximize the effectiveness of results while maintaining manageability of side effects, chemotherapy may be conducted in an escalation mode (increasing the dose). The combined approach involves using several drugs simultaneously. Each agent attacks abnormal cells at different stages of their life cycle, increasing the chance of their destruction.

Chemotherapy is usually conducted in cycles, where a treatment period is followed by a rest period for the body to recover. The Ichilov clinic conducts careful monitoring of the patient's condition and the effectiveness of therapy. As a preventive measure and for the treatment of side effects, medications are prescribed to prevent nausea, vomiting, protect the bone marrow, and prevent infections.

Steroids

Steroid treatment is part of a comprehensive therapeutic approach aimed at suppressing the pathological cloning of B-lymphocytes, reducing inflammation and associated symptoms. Treatment begins with high doses of steroids to achieve maximum therapeutic effect. The dosage and duration of the course are determined by the doctor based on the severity of the disease and the overall condition of the patient.

Steroids can be taken orally in the form of tablets or administered intravenously. Sometimes steroid medications may be combined with chemotherapeutic agents as part of induction therapy.

After the initial course of treatment, the steroid dose is often gradually reduced to minimize the risk of side effects and complications from prolonged use of high doses of steroids. The doctor will closely monitor the body's response to steroid therapy and adjust the dosage as necessary. After the main course of treatment, supportive therapy with lower doses of steroids may be prescribed to maintain the achieved result and prevent disease recurrence.

Targeted Therapy

Targeted treatment for heavy chain disease α-HCD is aimed not at destroying cloned cells in general, as chemotherapy does, but at affecting specific molecular targets that play a critical role in the growth, development, and survival of pathological cells. Targeted treatment includes monoclonal antibodies and inhibitor molecules specifically designed to interact with certain molecules and signaling pathways.

Mutations and targets for targeted drugs vary according to the specific characteristics of the patient, suggesting a strictly individualized approach.

Monoclonal Antibodies

Monoclonal antibodies may be used in the treatment of rare forms of lymphoproliferative disorders. These are proteins produced in laboratory conditions that mimic the natural ability of the immune system to recognize and attack selected targets on the surface of cancer cells.

In the treatment of diseases associated with abnormal immunoglobulins, monoclonal antibodies can target specific antigens expressed on the surface of pathologically altered B-lymphocytes or other targets that contribute to the survival and proliferation of these cells.

Treatment is prescribed after studying the biomarkers of the patient's cancer cells to determine the feasibility of using a particular antibody.

Stem Cell Transplantation

In some cases of severe disease progression, stem cell transplantation may be considered.

• The patient's own previously purified and processed stem cells are returned after a course of high-dose chemotherapy or radiotherapy (autologous transplantation). The main goal of this procedure is to destroy abnormal cells producing the pathogenic paraprotein and restore normal bone marrow function.
• In the case of allogeneic transplantation, stem cells are taken from a compatible donor. This approach may lead to the creation of a new immune system in the patient, thereby providing an advantage in the fight against abnormal cells.

This treatment option is considered when other methods are ineffective or in cases of disease recurrence.

Methods of Diagnosing the Disease

At the Ichilov clinic, the diagnosis of heavy alpha chain disease (IgA) is conducted in stages. This allows for the accurate recognition of this rare form of paraproteinemic diseases and the correct diagnosis. Generally, it takes three days to complete all tests and studies.

First Day

The doctor collects a complete medical history, checks symptoms, and conducts a physical examination, including an examination of the lymph nodes and abdominal cavity to detect signs of lymphadenopathy or hepatosplenomegaly.

Second Day

• Laboratory blood tests. The main diagnostic method is serological testing of blood for the presence of paraprotein. Serum analysis can reveal an increased level of proteins with abnormal immunoglobulins. Methods such as immunofixation and serum protein electrophoresis are used.
• Laboratory urine analysis. Detection of Bence-Jones protein in urine to identify light chains of immunoglobulins and other tests.
• Specific tests to assess organ and system function to determine the overall health status of the patient and the possible impact of the disease on various organs.
• Immunochemical analysis. This test allows determining the class of immunoglobulins and the type of light or heavy chain of immunoglobulin, which helps in identifying heavy alpha chain disease IgA.
• A complex of biochemical tests necessary to identify disease-related changes, such as anemia, renal failure, and other characteristic signs.
• Bone marrow examination. If deemed appropriate, a biopsy and analysis of the bone marrow are prescribed to detect plasmacytic infiltration or other abnormalities.
• Radiological examination. X-rays, CT, or MRI are used to identify lesions in the bones or enlargement of lymph nodes.
• Histological examination. A biopsy of affected tissues, such as the liver, lymph nodes, or intestines, may be required to confirm the diagnosis through histological analysis.

Third Day

The final diagnosis is made based on a combination of laboratory data, clinical manifestations, and instrumental studies. A key feature of heavy alpha chain disease is the presence of IgA alpha chain fragments in the serum, which are detected using specific immunochemical methods. At the Ichilov clinic, a collegial group of specialists from various fields is assembled to confirm the diagnosis. This approach allows for a comprehensive coverage of symptoms, correct interpretation of diagnostic results, and the development of an optimal treatment plan.

How Much Does Treatment Cost

Advantages of Treating Franklin's Disease in Israel

1. High qualifications and extensive practical experience of doctors and staff.
2. Personalized approach to treatment, innovative treatment methods, and the latest medical equipment.
3. Multidisciplinary team, research, and clinical trials.
4. Experience in stem cell transplantation and other innovative therapeutic methods.
5. Support for international patients, comfortable stay, and quality care.

The Ichilov clinic takes on the treatment of complex and rare diseases such as Franklin's disease. Modern communication means allow for a preliminary consultation with doctors specializing in paraproteinemic hematoblastoses. During a video call via Zoom or Skype, you can discuss a preliminary treatment plan and receive an assessment of the feasibility of therapeutic measures applicable to your specific case.